BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8186195)

  • 21. Multiple roles of the invariant chain in MHC class II function.
    Stumptner-Cuvelette P; Benaroch P
    Biochim Biophys Acta; 2002 Jan; 1542(1-3):1-13. PubMed ID: 11853874
    [No Abstract]   [Full Text] [Related]  

  • 22. Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo.
    Newcomb JR; Cresswell P
    J Immunol; 1993 Oct; 151(8):4153-63. PubMed ID: 8409392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers.
    Hmama Z; Gabathuler R; Jefferies WA; de Jong G; Reiner NE
    J Immunol; 1998 Nov; 161(9):4882-93. PubMed ID: 9794422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
    Busch R; Vturina IY; Drexler J; Momburg F; Hämmerling GJ
    Eur J Immunol; 1995 Jan; 25(1):48-53. PubMed ID: 7843252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of invariant chain (Ii)-calnexin interaction results in enhanced degradation of Ii but does not prevent the assembly of alpha beta Ii complexes.
    Romagnoli P; Germain RN
    J Exp Med; 1995 Dec; 182(6):2027-36. PubMed ID: 7500048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes.
    Peters PJ; Raposo G; Neefjes JJ; Oorschot V; Leijendekker RL; Geuze HJ; Ploegh HL
    J Exp Med; 1995 Aug; 182(2):325-34. PubMed ID: 7629497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail.
    Pieters J; Bakke O; Dobberstein B
    J Cell Sci; 1993 Nov; 106 ( Pt 3)():831-46. PubMed ID: 8308066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular and cell surface heterotypic associations of human leukocyte antigen-DR and human invariant chain.
    Triantafilou K; Triantafilou M; Wilson KM; Cherry RJ; Fernandez N
    Hum Immunol; 1999 Nov; 60(11):1101-12. PubMed ID: 10600008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural analysis of invariant chain subsets as a function of their association with MHC class II chains.
    Nguyen QV; Reyes VE; Humphreys RE
    Arch Biochem Biophys; 1995 Feb; 317(1):128-32. PubMed ID: 7872774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy.
    Romagnoli P; Germain RN
    J Exp Med; 1994 Sep; 180(3):1107-13. PubMed ID: 8064228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
    Hitzel C; van Endert P; Koch N
    J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular transport of class II MHC molecules directed by invariant chain.
    Lotteau V; Teyton L; Peleraux A; Nilsson T; Karlsson L; Schmid SL; Quaranta V; Peterson PA
    Nature; 1990 Dec; 348(6302):600-5. PubMed ID: 2250716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K; Miller J
    J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments.
    Anderson HA; Roche PA
    J Immunol; 1998 May; 160(10):4850-8. PubMed ID: 9590232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct transport of newly synthesized HLA-DR from the trans-Golgi network to major histocompatibility complex class II containing compartments (MIICS) demonstrated using a novel tyrosine-sulfated chimera.
    Davidson HW
    J Biol Chem; 1999 Sep; 274(38):27315-22. PubMed ID: 10480952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum.
    Schutze MP; Peterson PA; Jackson MR
    EMBO J; 1994 Apr; 13(7):1696-705. PubMed ID: 8157008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GTP-bound forms of rab6 induce the redistribution of Golgi proteins into the endoplasmic reticulum.
    Martinez O; Antony C; Pehau-Arnaudet G; Berger EG; Salamero J; Goud B
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1828-33. PubMed ID: 9050864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cathepsin B cleavage and release of invariant chain from MHC class II molecules follow a staged pattern.
    Xu M; Capraro GA; Daibata M; Reyes VE; Humphreys RE
    Mol Immunol; 1994 Jul; 31(10):723-31. PubMed ID: 8035834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-gamma-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules.
    Albanesi C; Cavani A; Girolomoni G
    J Invest Dermatol; 1998 Feb; 110(2):138-42. PubMed ID: 9457908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.